1. Home
  2. RDW vs ANIP Comparison

RDW vs ANIP Comparison

Compare RDW & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$9.05

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$77.09

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
ANIP
Founded
2020
2001
Country
United States
United States
Employees
1410
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
RDW
ANIP
Price
$9.05
$77.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$13.71
$110.00
AVG Volume (30 Days)
22.4M
297.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
$41.68
$21.01
Revenue Next Year
$20.25
$17.59
P/E Ratio
N/A
$60.72
Revenue Growth
N/A
2.47
52 Week Low
$4.87
$62.61
52 Week High
$26.64
$99.50

Technical Indicators

Market Signals
Indicator
RDW
ANIP
Relative Strength Index (RSI) 36.45 36.77
Support Level $8.39 $77.16
Resistance Level $10.43 $77.47
Average True Range (ATR) 0.75 2.51
MACD -0.07 -0.80
Stochastic Oscillator 20.06 4.32

Price Performance

Historical Comparison
RDW
ANIP

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: